Larson Financial Group LLC cut its holdings in GSK plc (NYSE:GSK – Free Report) by 52.7% during the fourth quarter, according ...
Atria Investments Inc cut its holdings in GSK plc (NYSE:GSK – Free Report) by 7.6% in the fourth quarter, according to the ...
NEW YORK CITY, NY / ACCESS Newswire / March 11, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, ...
The market was pleased with the recent earnings report from GSK plc ( LON:GSK ), despite the profit numbers being ...
GSK PLC closed 16.86% short of its 52-week high of £18.24, which the company reached on May 16th.
After a year of controversy and complaints, Sen. Elizabeth Warren is asking a federal watchdog to investigate GSK over its ...
Multinational pharmaceutical company GSK’s commitment to invest up to $800 million in its facility near Marietta may have ...
Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Receipts ("ADRs") of GSK plc (NYSE:GSK) between February 5, 2020 and August 14, 2022, both dates inclusive ...
GSK has joined a lengthening list of companies that have paused diversity, equity, and inclusion (DEI) targets under pressure ...
GSK’s ViiV Healthcare has shared clinical data on three potential long-acting HIV treatments, providing a look at how its ...
GlobalData on MSN11d
GSK reports positive outcomes from two Phase III trials of treatment for CRSwNPSecondary endpoint analyses from the trials showed 'significant improvements' in patients treated with the antibody.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback